Literature DB >> 32593798

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C Parker1, E Castro2, K Fizazi3, A Heidenreich4, P Ost5, G Procopio6, B Tombal7, S Gillessen8.   

Abstract

Entities:  

Keywords:  chemotherapy; hormone therapy; prostate cancer; radiotherapy; surgery

Year:  2020        PMID： 32593798     DOI： 10.1016/j.annonc.2020.06.011

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  112 in total

Review 1.  A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer.

Authors:  Bradley King; Jana McHugh; Katie Snape
Journal:  Appl Clin Genet       Date:  2021-05-20

2.  Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis.

Authors:  Lin Wang; Channing Paller; Hwanhee Hong; Lori Rosman; Anthony De Felice; Otis Brawley; G Caleb Alexander
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 13.506

Review 3.  Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer.

Authors:  Niamh M Keegan; Lisa Bodei; Michael J Morris
Journal:  Eur Urol Focus       Date:  2021-03-18

Review 4.  Prostate cancer.

Authors:  Richard J Rebello; Christoph Oing; Karen E Knudsen; Stacy Loeb; David C Johnson; Robert E Reiter; Silke Gillessen; Theodorus Van der Kwast; Robert G Bristow
Journal:  Nat Rev Dis Primers       Date:  2021-02-04       Impact factor: 52.329

5.  The Primacy of High B-Value 3T-DWI Radiomics in the Prediction of Clinically Significant Prostate Cancer.

Authors:  Alessandro Bevilacqua; Margherita Mottola; Fabio Ferroni; Alice Rossi; Giampaolo Gavelli; Domenico Barone
Journal:  Diagnostics (Basel)       Date:  2021-04-21

Review 6.  Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.

Authors:  David Gonzalez; Joaquin Mateo; Albrecht Stenzinger; Federico Rojo; Michelle Shiller; Alexander W Wyatt; Frédérique Penault-Llorca; Leonard G Gomella; Ros Eeles; Anders Bjartell
Journal:  J Pathol Clin Res       Date:  2021-02-25

7.  Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point-a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).

Authors:  G Francolini; G Timon; F Matrone; G Marvaso; L Nicosia; L Ognibene; A Vinciguerra; L E Trodella; C Franzese; P Borghetti; B A Jereczek-Fossa; S Arcangeli
Journal:  Clin Transl Oncol       Date:  2021-07-21       Impact factor: 3.405

8.  Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Authors:  Yuka Kubota; Shingo Hatakeyama; Tohru Yoneyama; Mihoko Sutoh Yoneyama; Itsuto Hamano; Sakae Konishi; Teppei Okamoto; Hayato Yamamoto; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  World J Urol       Date:  2021-03-06       Impact factor: 4.226

Review 9.  More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.

Authors:  Anniina Hyväkkä; Verneri Virtanen; Jukka Kemppainen; Tove J Grönroos; Heikki Minn; Maria Sundvall
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

Review 10.  Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.

Authors:  Alessia Cimadamore; Liang Cheng; Francesco Massari; Matteo Santoni; Laura Pepi; Carmine Franzese; Marina Scarpelli; Antonio Lopez-Beltran; Andrea Benedetto Galosi; Rodolfo Montironi
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.